Nargiza Nurillaeva

Prof. Dr. Nargiza Nurillaeva


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Muborakkhon ZokirovaMuborakkhon Zokirova
Muborakkhon Zokirova
AKAbdurakhman Kayumov
Abdurakhman Kayumov
NNNargiza Nurillaeva
Nargiza Nurillaeva
Jakhongir Gulomovich KhaydarovJakhongir Gulomovich Khaydarov
Jakhongir Gulomovich Khaydarov
Background: Cardiotoxic complications represent a major challenge in patients receiving anticancer therapy and may be influenced by interactions among demographic and genetic factors contributing to structural, functional, and electrophysiological myocardial abnormalities. This study aimed to evaluate the effects of age, sex, and genetic polymorphisms on the development of cardiotoxic complications in patients with acute leukemia. Methods: A total of 89 patients aged 18–78 years underwent electrocardiography, echocardiography, and molecular genetic analyses of polymorphisms in GPX4, SOD2, COL1A1, CAT, EDN1, and COMT. Results: Left ventricular hypertrophy (LVH) was detected in 58.4% of patients, reduced left ventricular ejection fraction (LVEF < 50%) in 23.6%, arrhythmias in 46.1%, and ischemic myocardial changes in 28.1%. Older age was significantly associated with LVH, reduced LVEF, and ischemic myocardial changes (all p < 0.05). Sex-specific differences showed a higher prevalence of rhythm disturbances in women and ischemic myocardial changes in men than in women. Individual genetic polymorphisms were significantly associated with specific cardiac phenotypes. Furthermore, combined genetic risk, defined as the presence of two or more unfavorable alleles, was significantly associated with higher rates of LVH, arrhythmias, and impaired myocardial contractility. Multivariate logistic regression identified COMT Val158Met, COL1A1 C1997A, SOD2 C14510A, and EDN1 Lys198Asn as independent genetic predictors of cardiotoxic complications. Conclusions: These findings support a polygenic model of cardiotoxicity and highlight the potential value of integrating demographic and genetic factors for personalized cardiovascular risk stratification, early detection, and prevention of treatment-related cardiac complications.

30 December 2024
Verified
Journal Article
Open access
PDF file
Munisakhon Majidovna MakhkamovaMunisakhon Majidovna Makhkamova
Munisakhon Majidovna Makhkamova
NNNargiza Nurillaeva
Nargiza Nurillaeva
Цель: Изучить взаимосвязь между метаболически ассоциированной стеатозной болезнью печени (МАСБП) и ишемической болезнью сердца (ИБС), выявить клинические аспекты их коморбидности. Материалы и методы: В исследование включены данные 110 пациентов с ИБС. Диагноз МАСБП устанавливался с использованием ультразвукового исследования печени и анализа метаболических параметров. Проводился корреляционный и регрессионный анализ связи между метаболическими нарушениями и тяжестью ИБС. Результаты: МАСБП выявлена у 77,3% пациентов с ИБС. Тяжесть стеатоза печени коррелировала с уровнем С-реактивного белка, индексом HOMA-IR и частотой острых коронарных событий. У пациентов с выраженной степенью стеатоза чаще диагностировались инфаркт миокарда и дислипидемия. Заключение: МАСБП является значимым фактором риска и утяжеляет течение ИБС. Ранняя диагностика и коррекция метаболических нарушений необходимы для улучшения прогноза пациентов с данной коморбидностью.

30 October 2025 in International Journal of Aquatic Research and Environmental Studies
Verified
Journal Article
Closed access
NNNargiza Nurillaeva
Nargiza Nurillaeva
Stress factors like variations in temperatures, salinity, hypoxia, and pollution are bad for the health and survival of aquatic life. Epigenetics has shown us that stress factors can leave lasting changes, such as DNA methylation, histone modifications, and non-coding RNA alterations, that do not equate to changes in the primary genetic sequence. Considering these changes helps in assessing the resilience of a species and broadening the survival options for the species in natural habitats as well as in aquaculture. The current research proposes an Epigenetic Stress Response Profiling (ESRP) approach, which combines methylation mapping in Whole-Genome Bisulfite Sequencing (WGBS), correlating the epigenome with RNA-Seq, and metabolomic fingerprinting to derive multi-omics whereby an individual is exposed to an environment and other factors are aberrated, and the individual responds adaptively. The ESRP approach uses model organisms, Oreochromis niloticus and Cyprinus carpio, exposed to thermal, hypoxic, and salinity stress. The acquired epigenomic signatures are interpreted through machine learning algorithms to determine candidate biosignatures correlated with/impacting stress and stress-related growth. The study outlines candidate stress-responsive gene networks and methylation hotspots that are actionable targets for stress tolerance and growth in selective breeding and conservation efforts. The integration of epigenetics with the management of aquaculture will aim to increase adaptive capacity, which will boost conservation of biodiversity and sustain fisheries. This will also aid in the conservation of biodiversity in aquaculture and fisheries in the face of changing environmental conditions.

30 September 2025
Verified
Journal Article
Open access
PDF file
NNNargiza Nurillaeva
Nargiza Nurillaeva
NSNigora Srojidinova
Nigora Srojidinova
Munisakhon Majidovna MakhkamovaMunisakhon Majidovna Makhkamova
Munisakhon Majidovna Makhkamova
LKLola Khafizova
Lola Khafizova
This review synthesizes current evidence on early biomarkers of endothelial dysfunction (ED) in cardiovascular disease (CVD), emphasizing their role in diagnosis, prognosis, and management. ED, characterized by reduced nitric oxide bioavailability and increased inflammation, serves as a reversible precursor to atherosclerosis, thrombosis, and events like myocardial infarction. Established biomarkers, including adhesion molecules, cytokines, and inflammatory markers, reflect endothelial activation and predict CVD risk, with recent studies confirming their utility in hypertension. Emerging focus on L-arginine derivatives, particularly asymmetric dimethylarginine (ADMA), highlights its specificity as an endogenous nitric oxide synthase inhibitor, associated with vascular impairment in hypertension, diabetes, and CVD. Clinical trials, such as the AtheroGene and Framingham Offspring studies, demonstrate ADMA’s prognostic value for major adverse events. Future directions advocate integrating ADMA into multi-biomarker panels with AI and omics for personalized medicine, addressing gaps in standardization and early detection. Non-invasive techniques like flow-mediated dilation and ultrasound-derived markers complement biomarkers for subclinical CVD assessment. Overall, biomarker-driven strategies promise enhanced CVD prevention and tailored therapies.

11 June 2025 in Exploration of Cardiology
Verified
Journal Article
Open access
PDF file
DYDilnora B. Yusupalieva
Dilnora B. Yusupalieva
RARano Alieva
Rano Alieva
UNUlugbek I. Nizamov
Ulugbek I. Nizamov
ASAleksandr Borisovich Shek
Aleksandr Borisovich Shek
SAShoxista Axmedova
Shoxista Axmedova
SSSurayyo M. Shukurdjanova
Surayyo M. Shukurdjanova
Aim: Coronary heart disease (CHD) has been the leading cause of death worldwide for several decades. Non-alcoholic fatty liver disease (NAFLD), the most common liver pathology, is considered a risk factor (RF) for the development of CHD and a predictor of an unfavourable prognosis. Our study aimed to compare cardiometabolic parameters in patients with CHD with and without NAFLD. Methods: The study prospectively included 85 patients with CHD, 61 with NAFLD (group I) and 24 without NAFLD (group II). In both groups, a comparative analysis of RF, anthropometric parameters, lipidogram, glycemic profile, brachiocephalic arteries (BCA) ultrasound (USD), and heart structural and geometric parameters according to echocardiography (EchoCG) and coronary calcium (CC) parameters was performed. Results: Patients with CHD and NAFLD had statistically significantly higher levels of total cholesterol, very low-density lipoproteins, triglycerides, insulin, heart structural parameters, and CC. Conclusions: Thus, the relationship between NAFLD and CHD is two-way, and liver diseases can exacerbate the course of cardiovascular diseases (CVD).

8 January 2026 in International Journal of Nutrology
Verified
Journal Article
Open access
PDF file
NNNargiza Nurillaeva
Nargiza Nurillaeva
AMAshurova Manzura
Ashurova Manzura
NXNigina Xalikova
Nigina Xalikova
XKXulkar Kasimova
Xulkar Kasimova
AAAli M. Ali
Ali M. Ali
TDTripti Dewangan
Tripti Dewangan
The metabolic syndrome of obesity has well-defined habitat-related mechanisms associated with obesity, insulin resistance, dyslipidemia, and inflammation, which collectively serve as habit-challenging and problematic issues related to obesity and obesity-related metabolic syndrome. Clearly, nutritional approaches signify the most important types of non-pharmacological treatment that can be explored and are extremely relevant. Two approaches of specific interest, perhaps because they have overlapping yet complementary mechanisms, are omega-3 fatty acids and probiotics. The current nutrologic study assessed the effect of Omega-3 fatty acid vs probiotic treatment on insulin sensitivity in an obese population with metabolic syndrome. Omega-3 fatty acids have many systemic effects (i.e., EPA and DHA), specifically with respect to the metabolic processing of the lipid component of an underlying disordered metabolic state, reducing pro-inflammatory cytokines, and improving insulin signalling at the cellular level. Alternatively, probiotics may come from a different basis and also work via a gut–metabolic axis, through the modulation of gut microbiota, re-establishing the functional gut barrier, and increasing short-chain fatty acids, which may affect glucose metabolism. The clinical examination of the results showed that both dietary strategies influenced different indices of insulin sensitivity, whereas Omega-3 fatty acids influenced lipids, and probiotics tended to be more representative of the modulation of gut-related pathways by the varied dietary strategies. So the effects are synthetically presented here, i.e., in summary, mainly because of the comparisons made, but the differences were examined in several contexts in order to demonstrate the complementary dietary gradients in the two interventions. In conclusion, flexibility for both therapies may be realized with a consideration for their combined use under personalized nutrology protocols to generate better metabolic outcomes. This nutrological viewpoint respects the same perceptions of dietary strategies being very nuanced with modifications to address the burden of metabolic syndrome and supports longer duration studies or trials with prolonged exposure to treatment, considering therapies in different populations, as well as exploring possibilities of dose response or synergistic treatment in metering changes.